These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 24051182
1. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A, Kant S, Singh SM. Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):196-208. PubMed ID: 24051182 [Abstract] [Full Text] [Related]
2. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation. Kumar A, Kant S, Singh SM. Chem Biol Interact; 2012 Jul 30; 199(1):29-37. PubMed ID: 22705712 [Abstract] [Full Text] [Related]
3. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype. Kant S, Kumar A, Singh SM. Biochim Biophys Acta; 2014 Jan 30; 1840(1):294-302. PubMed ID: 24060750 [Abstract] [Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL, Park JY, Kim EH, Jang HJ, Kwon M. Cancer Lett; 2016 Feb 01; 371(1):20-9. PubMed ID: 26607904 [Abstract] [Full Text] [Related]
5. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages. Vishvakarma NK, Singh SM. Immunol Lett; 2010 Nov 30; 134(1):83-92. PubMed ID: 20837061 [Abstract] [Full Text] [Related]
6. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. Vishvakarma NK, Singh SM. Biochimie; 2011 Oct 30; 93(10):1786-96. PubMed ID: 21722701 [Abstract] [Full Text] [Related]
8. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma. Gupta V, Singh SM. J Reprod Immunol; 2007 Jun 30; 74(1-2):90-102. PubMed ID: 17275917 [Abstract] [Full Text] [Related]
9. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells. Xie J, Wang BS, Yu DH, Lu Q, Ma J, Qi H, Fang C, Chen HZ. Int J Oncol; 2011 Feb 30; 38(2):409-17. PubMed ID: 21132264 [Abstract] [Full Text] [Related]
16. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance. Woolbright BL, Choudhary D, Mikhalyuk A, Trammel C, Shanmugam S, Abbott E, Pilbeam CC, Taylor JA. Mol Cancer Ther; 2018 Sep 30; 17(9):2004-2012. PubMed ID: 29907593 [Abstract] [Full Text] [Related]
17. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models. Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B. Oncotarget; 2016 Dec 06; 7(49):81741-81749. PubMed ID: 28082726 [Abstract] [Full Text] [Related]
18. α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton's lymphoma cells: role of altered cell survival-regulatory mechanisms. Kumar A, Kant S, Singh SM. Anticancer Drugs; 2013 Feb 06; 24(2):158-71. PubMed ID: 22932131 [Abstract] [Full Text] [Related]
19. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism. Xuan Y, Hur H, Ham IH, Yun J, Lee JY, Shim W, Kim YB, Lee G, Han SU, Cho YK. Exp Cell Res; 2014 Feb 15; 321(2):219-30. PubMed ID: 24342832 [Abstract] [Full Text] [Related]